Publications by authors named "Luisa Valer"

Claim this Profile
C
Clinical validation of saquinavir/ritonavir genotypic resistance score in protease-inhibitor-experienced patients.
Anne-Genevieve Marcelin, Philippe Flandre, Carmen de Mendoza, Benedicte Roquebert, Gilles Peytavin, Luisa Valer

Antivir Ther· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance of six different ritonavir-boosted protease inhibitor-based regimens in heavily antiretroviral-experienced HIV-infected patients.
Carmen de Mendoza, Luisa Valer, Esteve Ribera, Pablo Barreiro, Luz Martín-Carbonero

HIV Clin Trials· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of the HIV-1 protease mutation I47A in clinical practice and association with lopinavir resistance.
Carmen de Mendoza, Luisa Valer, Lee Bacheler, Theresa Pattery, Angélica Corral

AIDS· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive value of drug levels, HIV genotyping, and the genotypic inhibitory quotient (GIQ) on response to saquinavir/ritonavir in antiretroviral-experienced HIV-infected patients.
Luisa Valer, Carmen de Mendoza, Vincent Soriano

J Med Virol· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of virological response to atazanavir in protease inhibitor-experienced patients.
Ana Barrios, Ana Lucía Rendón, Oscar Gallego, Luz Martín-Carbonero, Luisa Valer

HIV Clin Trials· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of selection of K65R: tenofovir use and lack of thymidine analogue mutations.
Luisa Valer, Luz Martín-Carbonero, Carmen de Mendoza, Angélica Corral, Vincent Soriano

AIDS· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Failure to detect human immunodeficiency virus type 1 superinfection in 28 HIV-seroconcordant individuals with high risk of reexposure to the virus.
Bikram Chakraborty, Luisa Valer, Carmen De Mendoza, Vicente Soriano, Miguel E Quiñones-Mateu

AIDS Res Hum Retroviruses· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of virological response to lopinavir/ritonavir using the genotypic inhibitory quotient.
Daniel González de Requena, Oscar Gallego, Luisa Valer, Inmaculada Jiménez-Nácher, Vincent Soriano

AIDS Res Hum Retroviruses· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcome of HIV-infected patients with multinucleoside-resistant genotypes.
Oscar Gallego, Carmen d Mendoza, Pablo Labarga, Carmen Altisent, Juan González, Luisa Valer

HIV Clin Trials· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of drug levels and baseline genotype and phenotype on the virologic response to amprenavir/ritonavir-based salvage regimens.
Luisa Valer, Daniel González de Requena, Carmen de Mendoza, Luz Martin-Carbonero, Juan González-Lahoz

AIDS Patient Care STDS· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[HIV superinfection: clinical and biological implications].
Luisa Valer, Carmen de Mendoza, Vicente Soriano

Med Clin (Barc)· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the efficacy, safety and predictive value of HIV genotyping using distinct ritonavir-boosted protease inhibitors.
Pablo Barreiro, Nuria Camino, Carmen de Mendoza, Luisa Valer, Marina Núñez

Int J Antimicrob Agents· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resistance mutations in HIV-infected patients experiencing early failure with nelfinavir-containing triple combinations.
Marina Núńez, Carmen de Mendoza, Luisa Valer, Esperanza Casas, Soledad López-Calvo

Med Sci Monit· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of HIV genotyping and drug levels on the response to salvage therapy with saquinavir/ritonavir.
Luisa Valer, Carmen De Mendoza, Daniel González De Requena, Pablo Labarga, Adolfo García-Henarejos

AIDS· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis